Comparison between application of platelet rich plasma and mucosal advancement flap in patients with high transsphincteric anal fistulas: a randomized control trial.
anal fistula
mucosal advancement flap
platelet rich plasma
Journal
ANZ journal of surgery
ISSN: 1445-2197
Titre abrégé: ANZ J Surg
Pays: Australia
ID NLM: 101086634
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
revised:
27
02
2022
received:
13
11
2021
accepted:
06
03
2022
pubmed:
30
4
2022
medline:
12
5
2022
entrez:
29
4
2022
Statut:
ppublish
Résumé
There is still a search for a standard method of therapy for high anal fistulas. The aim of this trial was a comparison between a modified two stage minimally invasive procedure, consisting of loose-seton placement with the subsequent application of platelet rich plasma with mucosal advancement flap for the treatment of high transsphincteric anal fistulas of crypto-glandular origin. The study was designed as a prospective, randomized trial including 96 patients. Curettage of fistulous tracts, and loose-seton placement was performed in those patients with active inflammation, and if the diameter of a fistulous tract exceeded 3 mm. Afterwards, the patients were randomly assigned to either the PRP group or MAF group, consisting of 49 patients, and 47 patients, respectively. There was no significant statistical difference (p = 0.152) between both investigated groups of patients regarding closure of fistulas since it was achieved in 35 (71.43%) patients from group I, compared to 27 (57.45%) patients from group II. The diameter of fistulous tracts below 4 mm exerted a significant impact (p < 0.001) on the healing process after PRP application because fistulas with the narrow tracts were closed in 34 (87.18%) patients, whereas a wider fistula was healed in 1 (10%) patient. The local application of PRP in high, unbranched, and with narrow tracts trans-sphincteric anal fistulas of crypto-glandular origin, following loose-seton drainage is an effective, simple, and a safe method of therapy with a low rate of morbidity.
Sections du résumé
BACKGROUND
There is still a search for a standard method of therapy for high anal fistulas. The aim of this trial was a comparison between a modified two stage minimally invasive procedure, consisting of loose-seton placement with the subsequent application of platelet rich plasma with mucosal advancement flap for the treatment of high transsphincteric anal fistulas of crypto-glandular origin.
METHODS
The study was designed as a prospective, randomized trial including 96 patients. Curettage of fistulous tracts, and loose-seton placement was performed in those patients with active inflammation, and if the diameter of a fistulous tract exceeded 3 mm. Afterwards, the patients were randomly assigned to either the PRP group or MAF group, consisting of 49 patients, and 47 patients, respectively.
RESULTS
There was no significant statistical difference (p = 0.152) between both investigated groups of patients regarding closure of fistulas since it was achieved in 35 (71.43%) patients from group I, compared to 27 (57.45%) patients from group II. The diameter of fistulous tracts below 4 mm exerted a significant impact (p < 0.001) on the healing process after PRP application because fistulas with the narrow tracts were closed in 34 (87.18%) patients, whereas a wider fistula was healed in 1 (10%) patient.
CONCLUSION
The local application of PRP in high, unbranched, and with narrow tracts trans-sphincteric anal fistulas of crypto-glandular origin, following loose-seton drainage is an effective, simple, and a safe method of therapy with a low rate of morbidity.
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
1137-1141Informations de copyright
© 2022 Royal Australasian College of Surgeons.
Références
Narang SK, Keogh K, Alam NN, Pathak S, Daniels IR, Smart NJ. A systematic review of new treatments for cryptoglandular fistula in ano. Surgeon 2017; 15: 30-9.
van der Hagen SJ, Baeten CG, Soeters PB, van Gemert WG. Long-term outcome following mucosal advancement flap for high perianal fistulas and fistulotomy for low perianal fistulas: recurrent perianal fistulas: failure of treatment or recurrent patient disease? Int. J. Colorectal Dis. 2006; 21: 784-90.
Freymiller EG. Platelet-rich plasma: evidence to support its use. J. Oral Maxillofac. Surg. 2004; 62: 1046-8.
Eitan A, Koliada M, Bickel A. The use of the loose seton technique as a definitive treatment for recurrent and persistent high trans-sphincteric anal fistulas: a long-term outcome. J. Gastrointest. Surg. 2009; 13: 1116-9.
Mitalas LE, van Wijk JJ, Gosselink MP, Doornebosch P, Zimmerman DDE, Schouten WR. Seton drainage prior to transanal advancement flap repair: useful or not? Int. J. Colorectal Dis. 2010; 25: 1499-502.
Podetta M, Scarpa CR, Zufferey G et al. Mucosal advancement flap for recurrent complex anal fistula: a repeatable procedure. Int. J. Colorectal Dis. 2019; 34: 197-200.
Uribe N, Millán M, Minguez M et al. Clinical and manometric results of endorectal advancement flaps for complex anal fistula. Int. J. Colorectal Dis. 2007; 22: 259-64.
Moreno-Serrano A, García-Díaz JJ, Ferrer-Márquez M. Using autologous platelet-rich plasma for the treatment of complex fistulas. Rev. Esp. Enferm. Dig. 2016; 108: 123-8.
Van der Hagen SJ, Baeten CG, Soeters PB, van Gemert WG. Autologous platelet-derived growth factors (platelet-rich plasma) as an adjunct to mucosal advancement flap in high cryptoglandular perianal fistulae: a pilot study. Colorectal Dis. 2011; 13: 215-8.
Streit-Ciećkiewicz D, Futyma K, Miotła P, Grzybowska ME, Rechberger T. Platelet-rich plasma as adjuvant therapy for recurrent vesicovaginal fistula: a prospective case series. J. Clin. Med. 2019; 8: 2122.
Gupta S, Goil P, Thakurani T. Autologous platelet rich plasma as a preparative for resurfacing burn wounds with split thickness skin grafts. World J. Plast. Surg. 2020; 9: 29-32.
de la Portilla F, Jiménez-Salido A, Araujo-Miguez A et al. Autologous platelet-rich plasma in the treatment of perianal fistula in Crohn's disease. J. Gastrointest. Surg. 2020; 24: 2814-282.
Kontovounisios C, Tekkis P, Tan E, Rasheed S, Darzi A, Wexner SD. Adoption and success rates of perineal procedures for fistula-in-ano: a systematic review. Colorectal Dis. 2016; 18: 441-58.
Emile SH, Elfeki H, Thabet W et al. Predictive factors for recurrence of high transsphincteric anal fistula after placement of seton. J. Surg. Res. 2017; 213: 261-8.
Mei Z, Wang Q, Zhang Y et al. Risk factors for recurrence after anal fistula surgery: a meta-analysis. Int. J. Surg. 2019; 69: 153-64.